Love Pharma Inc. (formerly Glenbriar Technologies Inc.) has a thin disclosure history in our data (latest filing: 25 August 2022). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
4 of 4 declarations
Love Pharma Inc., formerly Glenbriar Technologies Inc., is a company listed on the Toronto Stock Exchange that focuses on the development of pharmaceutical products. It aims to enhance health and wellness through innovative solutions.